Troxerutin Vramed, capsules 300 mg 50 pcs

Troxerutin Vramed has venotonic, angioprotective, anti-inflammatory, anti-edema, antioxidant effect.Flanovoid (rutin derivative), has P-vitamin activity; has venotonic, angioprotective, anti-inflammatory and anti-edema effect.

Its pharmacodynamic properties are connected with participation of bioflavonoids of troxerutin in redox processes and inhibition of hyaluronidase.

Inhibiting hyaluronidase, troxerutin stabilizes the hyaluronic acid of cell membranes and reduces capillary permeability and fragility and increases their tone.

It has antioxidant activity, thus preventing oxidation of ascorbic acid, adrenaline and lipids. It prevents damage to the basal membrane of endothelial cells when it is exposed to various factors.

Troxerutin reduces exudative inflammation in the vascular wall by limiting the adhesion of platelets to its surface. As a result of treatment with troxerutin the feeling of heaviness in legs disappears, swelling of tissues decreases, trophicity improves

.

Indications

Chronic venous insufficiency with such manifestations as static heaviness in the legs, leg ulcers, trophic skin lesions;
varicose veins, superficial thrombophlebitis, periphlebitis, phlebothrombosis, varicose dermatitis, postthrombotic syndrome, hemorrhoids, post-traumatic edema and hematomas, hemorrhagic diathesis with increased capillary permeability, capillary toxicosis (including measles, scarlet fever, influenza), diabetic microangiopathy, retinopathy, vascular side effects of radiation therapy;
as a prophylactic after vein surgery.

Pharmacological effect

Troxerutin Vramed has venotonic, angioprotective, anti-inflammatory, decongestant, antioxidant effects. Flanovoid (rutin derivative) has P-vitamin activity; has a venotonic, angioprotective, anti-inflammatory and anti-edematous effect.

Its pharmacodipamic properties are associated with the participation of the bioflavonoids troxerutin in redox processes and inhibition of hyaluronidase.

By inhibiting hyaluronidase, troxerutin stabilizes the hyaluronic acid of cell membranes and reduces the permeability and fragility of capillaries, and increases their tone.

It has antioxidant activity, which prevents the oxidation of ascorbic acid, adrenaline and lipids. Prevents damage to the basement membrane of endothelial cells when exposed to various factors.

Troxerutin reduces exudative inflammation in the vascular wall, limiting the adhesion of platelets to its surface. As a result of treatment with troxerutin, the feeling of heaviness in the legs disappears, tissue swelling decreases, and trophism improves

Active ingredient

Troxerutin

Composition

1 capsule contains:

active ingredient:

troxerutin 300 mg;

excipients:

lactose monohydrate – 5 mg;

colloidal silicon dioxide – 8 mg;

macrogol 6000 – 15 mg;

magnesium stearate – 7 mg;

shell:

gelatin; titanium dioxide – 2%; quinoline yellow dye – 0.75%; sunset yellow dye – 0.0059%; gelatin – up to 100%

Pregnancy

Contraindicated in the first trimester of pregnancy and during breastfeeding; in the second and third trimesters of pregnancy, it can only be used as prescribed by a doctor.

Contraindications

Hypersensitivity, peptic ulcer of the stomach and duodenum, chronic gastritis (in the acute phase).

Side Effects

Allergic reactions (skin rash), erosive and ulcerative lesions of the gastrointestinal tract, headache.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C

Shelf life

5 years

Manufacturer

Sopharma JSC, Bulgaria